The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 16,101–16,200 of 31,469
Halvorsen, B. L., Heggen, E., Ueland, T., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0706 · Cited by 18
Yoshimura, E., Kumahara, H., Tobina, T., Ayabe, M., Matono, S., Anzai, K., Higaki, Y., Kiyonaga, A., & Tanaka, H. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.03.003 · Cited by 18
Muhammad, S. A., Bilbis, L. S., Saidu, Y., et al. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/134723 · Cited by 18
Huri, H. Z., Makmor‐Bakry, M., Hashim, R., Mustafa, N., & Ngah, W. Z. W. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9682-7 · Cited by 19
Petchey, W. G., Howden, E. J., Johnson, D. W., Hawley, C. M., Marwick, T. H., & Isbel, N. M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06880810 · Cited by 18
Mohamed, W. S. (2014) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000122 · Cited by 18
Burghardt, K. J., Gardner, K. N., Johnson, J. W., & Ellingrod, V. L. (2013) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2013/596945 · Cited by 18
Biochemical Characteristics and Risk Factors for Insulin Resistance at Different Levels of Obesity
Guerrero‐Romero, F., Aradillas-García, C., Simental‐Mendía, L. E., Torres-Rodríguez, M. L., Mendoza, E. D. L. C., Rosales-Cervantes, J., Ramírez, G. R., & Rodríguez‐Morán, M. (2013) · PEDIATRICS · doi:10.1542/peds.2012-1421 · Cited by 18
Gómez‐García, A., Nieto-Alcantar, E., Gómez-Alonso, C., Figueroa-Núñez, B., & Álvarez-Aguilar, C. (2010) · Atención Primaria · doi:10.1016/j.aprim.2009.10.015 · Cited by 18
Goossens, G. H., Blaak, E. E., Schiffers, P. M. H., Saris, W. H. M., & van Baak, M. A. (2006) · Diabetologia · doi:10.1007/s00125-006-0458-2 · Cited by 18
Resistencia a la insulina en adolescentes con sobrepeso y obesidad
Pajuelo, J., Pando, R., Leyva, M. G. C., et al. (2013) · Anales de la Facultad de Medicina · doi:10.15381/anales.v67i1.1291 · Cited by 18
Insulin resistance induced by high-fructose diet potentiates carbon tetrachloride hepatotoxicity
Pooranaperundevi, M., Sumiyabanu, M. S., Viswanathan, P., Sundarapandiyan, R., & Anuradha, C. V. (2010) · Toxicology and Industrial Health · doi:10.1177/0748233709359273 · Cited by 18
Eholié, S. P., Lacombe, K., Krain, A., Diallo, Z., Ouiminga, M., Campa, P., Bouchaud, O., Bissagnené, E., & Girard, P. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0164 · Cited by 18
Tran, M., Young, M. E., Jefferies, A. J., Hryciw, D., Ward, M. M., Fletcher, E. L., Wlodek, M., & Wadley, G. (2015) · Physiological Reports · doi:10.14814/phy2.12556 · Cited by 17
Penesová, A., Rádiková, Ž., Vlček, M., Kerlik, J., LUKÁČ, J., Rovensky, J., & Imrich, R. (2013) · Physiological Research · doi:10.33549/physiolres.932359 · Cited by 18
Hull, M., Rollet, K., Moodie, E. E. M., Walmsley, S. L., Cox, J., Potter, M., Cooper, C., Pick, N., Saeed, S., & Klein, M. B. (2012) · AIDS · doi:10.1097/qad.0b013e32835612ce · Cited by 18
Influence of a prudent diet on circulating cathepsin S in humans
Jobs, E. N., Adamsson, V., Larsson, A. O., Jobs, M., Nerpin, E., Ingelsson, E., Ärnlöv, J., & Risérus, U. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-84 · Cited by 18
Navas‐Carretero, S., Abete, I., Zulet, M. Á., & Martínez, J. A. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-74 · Cited by 18
UNDERWOOD, P. C., Chamarthi, B., Williams, J. S., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.09.018 · Cited by 18
Garg, S., Madhu, S. V., & Suneja, S. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.154512 · Cited by 18
Niu, Y., Zhang, W., YANG, Z. K., et al. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0079-0 · Cited by 18
Sakane, N., Sato, J., Tsushita, K., Tsujii, S., Kotani, K., Tominaga, M., Kawazu, S., Sato, Y., Usui, T., Kamae, I., et al. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2013-000003 · Cited by 20
Wang, W., Liou, T., Lee, W., Hsu, C.-T., Lee, M.-F., & Chen, H.-H. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.10.011 · Cited by 18
Impact of phosphodiesterase 8B gene rs4704397 variation on thyroid homeostasis in childhood obesity
Grandone, A., Perrone, L., Cirillo, G., Sessa, A. D., Corona, A. M., Amato, A., Cresta, N., Romano, T., & del Giudice, E. M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0703 · Cited by 18
Fasting Indicators of Insulin Sensitivity: Effects of Ethnicity and Pubertal Status
Adam, T. C., Hasson, R. E., Lane, C. J., Davis, J. N., Weigensberg, M. J., Spruijt‐Metz, D., & Goran, M. I. (2011) · Diabetes Care · doi:10.2337/dc10-1593 · Cited by 18
Dietary composition and its associations with insulin sensitivity and insulin secretion in youth
Henderson, M., Benedetti, A., & Gray-donald, K. (2013) · British Journal of Nutrition · doi:10.1017/s0007114513002572 · Cited by 15
Brotons, C., de la Figuera, M., Franch‐Nadal, J., Arístegui, I., Azeredo, R. R., García, M., & Gomis, R. (2008) · Medicina Clínica · doi:10.1016/s0025-7753(08)72284-x · Cited by 18
Ramachandran, A., Snehalatha, C., Shetty, A. S., & Nanditha, A. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03392.x · Cited by 18
Diz-Lois, M. T., García‐Buela, J., Suarez, F., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0508 · Cited by 18
Hosseinpanah, F., Borzooei, S., Barzin, M., Farshadi, M., Sarvghadi, F., & Azizi, F. (2012) · PubMed · Cited by 18
Baky, A. A. E. (2011) · Cited by 18
Kawamoto, R., Katoh, T., Ninomiya, D., Kumagi, T., Abe, M., & Kohara, K. (2016) · Endocrine Research · doi:10.3109/07435800.2015.1094085 · Cited by 18
Cardiometabolic Health in Submariners Returning from a 3-Month Patrol
Gasier, H. G., Young, C. R., Gaffney‐Stomberg, E., McAdams, D. C., Lutz, L. J., & McClung, J. P. (2016) · Nutrients · doi:10.3390/nu8020085 · Cited by 21
Slusher, A. L., & Huang, C. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0464 · Cited by 18
Older adults have an altered chylomicron response to a high-fat meal
Milan, A. M., Nuora, A., Pundir, S., Pileggi, C. A., Markworth, J. F., Linderborg, K. M., & Cameron‐Smith, D. (2016) · British Journal Of Nutrition · doi:10.1017/s000711451500505x · Cited by 21
Ghaffari, M.-A., Payami, S. A., Payami, S. P., et al. (2016) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2016.62013 · Cited by 18
Asferg, C. L., Nielsen, S. J., Andersen, U. B., Linneberg, A. R., Møller, D. V., Hedley, P. L., Christiansen, M., Goetze, J. P., & Jeppesen, J. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt145 · Cited by 18
Effects of telmisartan and pioglitazone on high fructose induced metabolic syndrome in rats
Shahataa, M. G., Mostafa‐Hedeab, G., Ali, E. F., Mahdi, E. A., & Mahmoud, F. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0090 · Cited by 18
Torun, E., Genç, H., Gönüllü, E., et al. (2013) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2012-0245 · Cited by 18
Reynés, B., García-Ruiz, E., Palou, A., & Oliver, P. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516001173 · Cited by 18
Jago, R., Drews, K. L., Otvos, J. D., Willi, S. M., Buse, J. B., & for the HEALTHY Study Group (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.84 · Cited by 17
Petrović, G., Bjelaković, G., Benedeto-Stojanov, D., Nagorni, A. V., Brzački, V., & Marković-Živković, B. (2016) · Vojnosanitetski pregled · doi:10.2298/vsp150514093p · Cited by 19
Başyığıt, S., Uzman, M., Kefeli, A., et al. (2015) · PubMed · Cited by 18
Review article Insulin resistance and its consequences in chronic hepatitis C
Kukla, M., Piotrowski, D., Waluga, M., & Hartleb, M. (2015) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2015.51375 · Cited by 18
Demmer, D. L., Beilin, L. J., Hands, B. P., Burrows, S., Pennell, C. E., Lye, S. J., Mountain, J. A., & Mori, T. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162164 · Cited by 18
Rämö, J. T., Kaye, S. M., Jukarainen, S., Bogl, L. H., Hakkarainen, A., Lundbom, J., Lundbom, N. M. I., Rissanen, A., Kaprio, J. A., Matikainen, N., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3512 · Cited by 20
Cifre, M., Díaz‐Rúa, R., Varela‐Calviño, R., Reynés, B., Pericás‐Beltrán, J., Palou, A., & Oliver, P. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600353 · Cited by 18
Triheptanoin: long-term effects in the very long-chain acyl-CoA dehydrogenase-deficient mouse
Tucci, S., Floegel, U., Beermann, F., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m072033 · Cited by 18
Rizi, E. P., Baig, S., Shabeer, M., Teo, Y., Mok, S. F., Loh, T. P., Magkos, F., Virtue, S., Vidal‐Puig, A., Tai, E. S., et al. (2016) · Nutrition Journal · doi:10.1186/s12937-016-0219-0 · Cited by 18
Ribeiro, V. B., Kogure, G. S., dos Reis, R. M., Gastaldi, A. C., de Araújo, J. E., Mazon, J. H., Borghi‐Silva, A., & de Souza, H. C. D. (2016) · PubMed Central · doi:10.70252/dgcj5295 · Cited by 18
Presence of early stage cancer does not impair the early protein metabolic response to major surgery
ENGELEN, M. P. K. J., Klimberg, V. S., Allasia, A., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12173 · Cited by 18
Xia, Y., Fu, Y., Wang, Y., Qian, Y., Li, X., Xu, H., Zou, J., Guan, J., Yi, H., Meng, L., et al. (2017) · Scientific Reports · doi:10.1038/srep41687 · Cited by 19
Type 2 diabetes after gestational diabetes mellitus in South Asian women in the United States
Gadgil, M. D., Oza‐Frank, R. B., Kandula, N. R., & Kanaya, A. M. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2891 · Cited by 21
Morioka, T., Emoto, M., Yamazaki, Y., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12657 · Cited by 18
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome
Trevano, F. Q., Seravalle, G., Macchiarulo, M., Villa, P., Valena, C., Dell’Oro, R., Mancia, G., & Grassi, G. M. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001370 · Cited by 18
Aradillas-García, C., Cruz, M., Elva, P.-L., María, E., Malacara, J. M., Aduna, R., Peralta‐Romero, J., Burguete-García, A. I., & Jorge, A. (2017) · Journal of Biomedical Research · doi:10.7555/jbr.30.20150169 · Cited by 18
Total Serum Antioxidant Capacity in Healthy Normal Weight and Asymptomatic Overweight Adults
Petelin, A., Tedeschi, P., Maietti, A., Jurdana, M., Brandolini, V., & Pražnikar, Z. J. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-107783 · Cited by 18
Huang, J., Yeh, M., Huang, C., Huang, C., Tsai, P., Tai, C., Yang, H., Dai, C., Hsieh, M., Chen, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174394 · Cited by 18
Gökçebay, D. G., Azik, F. M., Bayram, C., Erdem, A. Y., Fettah, A., Işık, P., Yaralı, N., Demirel, F., Tunç, B., & Özbek, N. Y. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0306 · Cited by 18
Pradeep, S. R., & Srinivasan, K. (2017) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0140 · Cited by 18
Yokomichi, H., Ohde, S., Takahashi, O., Mochizuki, M., Takahashi, A., Yoda, Y., Tsuji, M., Akiyama, Y., & Yamagata, Z. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014684 · Cited by 18
Mele, C., Grugni, G., Mai, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03538-7 · Cited by 18
Serum Omentin-1 Levels and Endothelial Dysfunction in Obesity
Çimen, A. (2017) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2017.138 · Cited by 18
Pérez-Suárez, I., Ponce‐González, J. G., Calle-Herrero, J. D. L., Losa‐Reyna, J., Martín-Rincón, M., Morales‐Álamo, D., Santana, A., Holmberg, H., & Calbet, J. A. L. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00454.2017 · Cited by 19
Sleep duration and progression to diabetes in people with prediabetes defined by HbA1c concentration
Kim, C., Chang, Y., Sung, E., & Ryu, S. (2017) · Diabetic Medicine · doi:10.1111/dme.13432 · Cited by 19
Gentile, M., Iannuzzo, G., Mattiello, A., Rubba, F., Panico, S., & Rubba, P. (2017) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-13 · Cited by 18
Zhou, D., Li, S., Li, W., Yin, T., Xu, W., Zhang, J., & Yang, J. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.09.017 · Cited by 19
Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus
Zhou, Z., Ju, H., Sun, M., Chen, H., Fu, Q.-P., & Jiang, D. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.023 · Cited by 19
Mancini, A., Segni, C. D., Bruno, C., Olivieri, G., Guidi, F., Silvestrini, A., Meucci, E., Orlando, P., Silvestri, S., Tiano, L., et al. (2017) · Endocrine · doi:10.1007/s12020-017-1468-1 · Cited by 17
Genome-wide meta-analysis identifies novel determinants of circulating serum progranulin
Tönjes, A., Scholz, M. R., Krüger, J., Krause, K., Schleinitz, D., Kirsten, H., Gebhardt, C., Marzi, C., Grallert, H., Ladenvall, C., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx413 · Cited by 18
Yang, Q., Fu, C., Xiao, J., & Ye, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8315 · Cited by 18
Pérez-Matos, M. C., Alvarez, M. C. M., Toloza, F. J. K., Ricardo-Silgado, M. L., Mantilla-Rivas, J. O., Pinzón-Cortés, J. A., Pérez-Mayorga, M., Jiménez, E., Guevara, E., & Mendivil, C. O. (2017) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.41.6.466 · Cited by 18
Clinical significance of neuregulin 4 (NRG4) in gestational diabetes mellitus
Eken, M. K., Abide, Ç. Y., Ersoy, G. Ş., Ensarı, T. A., Pekin, O., & Çevik, Ö. D. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1420772 · Cited by 18
miR-320 mediates diabetes amelioration after duodenal-jejunal bypass via targeting adipoR1
Guo, W., Shao, Y., Yong, D., Liu, S., Guangyong, Z., & Hu, S. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.03.007 · Cited by 18
Akter, S., Eguchi, M., Nanri, A., et al. (2018) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.01.011 · Cited by 18
Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway
Yu, Q., Chen, M., Yang, Y., Zhou, X., Shao, S., Wang, D. W., & Yuan, G. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8737 · Cited by 18
Nascimbeni, F., Romagnoli, D., Ballestri, S., Baldelli, E., Lugari, S., Sirotti, V., Giampaoli, V., & Lonardo, A. (2018) · Diseases · doi:10.3390/diseases6010017 · Cited by 18
Ghosh, A. K., Mau, T., O’Brien, M., & Yung, R. L. (2018) · Aging · doi:10.18632/aging.101426 · Cited by 18
Li, Y., Yang, X., Gu, H., Snellingen, T., Liu, X.-P., & Liu, N. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.03.21 · Cited by 17
Tsai, M., Yu, H.-W., Liu, T., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00110 · Cited by 18
Mäntyselkä, A., Lindi, V., Viitasalo, A., Eloranta, A., Ågren, J., Väisänen, S., Voutilainen, R., Laitinen, T. P., Lakka, T. A., & Jääskeläinen, J. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00184 · Cited by 18
Toàn, N. L., Hoan, N. V., Cuong, D. V., Dung, N. V., Dung, P. T., Hang, N. T., Dieu, D. T. H., Chung, D. T., Sơn, H. A., Phong, P. X., et al. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0343-4 · Cited by 19
Gravio, C. D., Krishnaveni, G. V., Somashekara, R., Veena, S. R., Kumaran, K., Krishna, M., Karat, S. C., & Fall, C. H. D. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0144-8 · Cited by 18
Elhelbawy, M., Abdel‐Razek, W., Alsebaey, A., Hashim, M. S., Elshenawy, H., & Waked, I. A. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001215 · Cited by 18
de Luis, D. A., Primo, D., Izaola, O., Hoyos, E. G., Gómez, J. J. L., Ortolá, A., & Aller, R. (2018) · Nutrition · doi:10.1016/j.nut.2018.08.018 · Cited by 18
Zhang, Y., Thai, K., Jin, T., Woo, M., & Gilbert, R. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-32351-z · Cited by 20
Metabolic disorders and inflammation are associated with familial combined hyperlipemia
Díaz-Ruiz, M., Martínez-Triguero, M. L., López‐Ruiz, A., la Cruz, F. F.-D., Bañuls, C., & Hernández‐Mijares, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.09.009 · Cited by 19
Effect of personalized moderate exercise training on Wistar rats fed with a fructose enriched water
Dupas, J., Féray, A., Guernec, A., Pengam, M., Inizan, M., Guerrero, F., Mansourati, J., & Goanvec, C. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0307-6 · Cited by 21
Hulst, A. V., Paradis, G., Harnois‐Leblanc, S., Benedetti, A., Drapeau, V., & Henderson, M. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy189 · Cited by 18
Kuliczkowska-Płaksej, J., Pasquali, R., Milewicz, A., Lwow, F., Jędrzejuk, D., & Bolanowski, M. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0759-7533 · Cited by 18
Leitão, J., Carvalhana, S. C., Silva, A. P., et al. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.26586 · Cited by 18
Carter, S., Lemieux, I., Li, Z., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., Després, J., & Picard, F. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.12.016 · Cited by 18
la Cruz-Color, L. D., Nazará, Z., Maldonado‐González, M., Navarro-Muñíz, E., Domı́nguez-Rosales, J. A., Torres-Baranda, J. R., Ruelas-Cinco, E. D. C., Ramírez-Meza, S. M., & Ruiz‐Madrigal, B. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0829-6324 · Cited by 18
Roebroek, Y. G. M., Paulus, G. F., van Mil, E., Vreugdenhil, A. C. E., Winkens, B., Nederkoorn, C., Stehouwer, C. D. A., Greve, J.-W. M., Bouvy, N. D., & van Heurn, E. L. W. (2019) · BMC Pediatrics · doi:10.1186/s12887-019-1395-9 · Cited by 18
Huang, H., Aminian, A., Hassan, M., Dan, O., Axelrod, C. L., Schauer, P. R., Brethauer, S. A., & Kirwan, J. P. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03800-z · Cited by 20
Walker, T. J., Heredia, N. I., Lee, M., Laing, S. T., Fisher‐Hoch, S. P., McCormick, J. B., & Reininger, B. M. (2019) · BMC Public Health · doi:10.1186/s12889-019-6439-4 · Cited by 18
Mehrpouya‐Bahrami, P., Miranda, K., Singh, N. P., Zumbrun, E. E., Nagarkatti, M., & Nagarkatti, P. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005094 · Cited by 18
Guareschi, Z. M. N. D. C., Valcanaia, A. C., Ceglarek, V. M., Hotz, P. G., Amaral, B. K. D., de Souza, D. W., de Souza, T. A., Nardelli, T. R., Rentz, T., Leite, N. C., et al. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519000667 · Cited by 20
Utility of ALT Concentration in Men and Women with Nonalcoholic Fatty Liver Disease: Cohort Study
Sung, K., Lee, M. Y., Lee, J., Lee, S.-H., Kim, S.-H., & Kim, S. H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040445 · Cited by 18
Ardiansyah, A., David, W., Handoko, D. D., et al. (2019) · Nutrition & Food Science · doi:10.1108/nfs-12-2018-0340 · Cited by 18
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
